Is a complete FRA/ECX research report available?

No complete published report is available for fra/ECX (FRA/ECX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/ECX (FRA/ECX)

Frankfurt Stock Exchange: FRA/ECX · EUR

€0.94

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/ECX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	824.4K
Revenue (ttm)	24K
Net income (ttm)	-314K
EPS (ttm)	-€0.36
Shares out	877K
Volume	871
Beta	0.85

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 24K
Net income (ttm): -314K
EPS (ttm): -€0.36
Market cap: 824.4K

All FRA/ECX indicators

Market & fundamental data

Available fields

158

Groups with data

Currency

EUR

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	3
Employees Change	1%
Employees Change Percent	50
Enterprise value	EUR 11.8M
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	DE000A37FT41
Last refreshed	2026-07-27
Market cap	EUR 824,357
Price	EUR 0.94
Price currency	EUR
Rev Per Employee	8,000x
Sector	Healthcare
Sector PE	40.49
Sector PE Fwd	15.21
Sic	2835
Symbol	fra/ECX
Website	https://www.epigenomics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-38.09%
FCF yield	-64.66%
P/B ratio	412.18x
P/S ratio	34.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 24,000
Gross Profit Growth3 Y	-61.63%
Gross Profit Growth5 Y	-49.02%
Net Income	EUR -314,000
Pretax Margin	-1,308.33%
Profit Per Employee	EUR -104,667
ROA	-2.03
Roa5y	-16.4
ROCE	-3.31
ROE	-31,400
ROIC	-2.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-48.35%
Cagr1y	5.21%
Cagr3y	-33.28%
Cagr5y	-47.83%
Revenue Growth3 Y	-70.11x
Revenue Growth5 Y	-50.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0
Assets	EUR 11.6M
Cash	EUR 414,000
Current Assets	EUR 439,000
Current Liabilities	EUR 73,999
Debt	EUR 11.4M
Debt Equity	EUR 5,691
Debt FCF	EUR -21.35
Equity	EUR 2,000
Liabilities	EUR 11.6M
Long Term Assets	EUR 11.2M
Long Term Liabilities	EUR 11.5M
Net Cash	EUR -11M
Net Cash By Market Cap	EUR -1,330
Net Debt Equity	EUR 5,484
Tangible Book Value	EUR 2,000
Tangible Book Value Per Share	EUR 0
WACC	0.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.93
Net Working Capital	EUR -48,999
Quick ratio	5.72
Working Capital	EUR 365,001
Working Capital Turnover	EUR 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.86%
1Y total return	5.21%
200-day SMA	0.93
3Y total return	-70.31%
50-day SMA	0.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.13%
All Time High	1,187.4
All Time High Change	-99.92%
All Time High Date	2017-07-05
All Time Low	0.5
All Time Low Change	88%
All Time Low Date	2024-06-28
ATR	0.05
Beta	0.85
Beta1y	1.45
Beta2y	0.83
Ch YTD	4.44
High	0.94
High52	1.59
High52 Date	2025-11-12
High52ch	-40.88%
Low	0.94
Low52	0.84
Low52 Date	2026-02-09
Low52ch	11.91%
Ma50ch	2.58%
Price vs 200-day SMA	1.57%
RSI	50.21
RSI Monthly	34.02
RSI Weekly	49.77
Sharpe ratio	0.71x
Sortino ratio	1.43
Total Return	-0%
Tr YTD	6.38
Tr1m	10.05%
Tr3m	2.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -382,000
Operating margin	-1,591.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	622,111%
Shares Institutions	0%
Shares Out	876,976
Shares Qo Q	0.01%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -533,000
Average Volume	312.95x
Bv Per Share	0
Ch10y	-99.88
Ch1m	8.05
Ch1y	3.3
Ch3m	1.08
Ch3y	-70.85
Ch5y	-96.2
Ch6m	4.44
Change	0%
Change From Open	0
Close	0.94
Days Gap	0
Depreciation Amortization	12,000
Dollar Volume	818.7
Earnings Date	2026-07-30
EBIT	EUR -382,000
EBITDA	EUR -370,000
EPS	EUR -0.36
F Score	2
FCF	EUR -533,000
FCF EV Yield	-4.52x
FCF Per Share	EUR -0.61
Fiscal Year End	December
Founded	1,998
Investing CF	20,000
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2025-12-31
Last Split Date	2023-12-08
Last Split Type	Reverse
Ma150	0.93
Ma150ch	0.58%
Ma20	0.96
Ma20ch	-2.41%
Net CF	-514,000
Next Earnings Date	2026-07-30
Open	0.94
Price Date	2026-07-24
Ptbv Ratio	412.2
Relative Volume	3.2x
Revenue	24,000x
Tr6m	6.38%
Volume	871
Z Score	-10.77

FRA/ECX (FRA/ECX)

Coverage state: Market snapshot only — no published research

Generate the first FRA/ECX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/ECX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/ECX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/ECX

Frequently asked questions